Volume 53, Issue 4, Pages (April 1998)

Slides:



Advertisements
Similar presentations
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Advertisements

Acid-base profile in patients on PD
Volume 59, Issue 4, Pages (April 2001)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Volume 66, Issue 6, Pages (December 2004)
Volume 54, Issue 2, Pages (August 1998)
Linear and logistic regression analysis
Acid-base profile in patients on PD
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Volume 64, Issue 6, Pages (December 2003)
Use of icodextrin in high transport ultrafiltration failure
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Glucose sparing in peritoneal dialysis: Implications and metrics
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Volume 57, Issue 6, Pages (June 2000)
Volume 59, Issue 1, Pages (January 2001)
Tubo-Ovarian Abscess Presenting as Culture-Negative Peritonitis in a Patient Undergoing Treatment With Peritoneal Dialysis  Cheng-Lin Lang, MD, Chih-Kang.
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real?  S. Andrulli, S. Di Filippo, F. Locatelli 
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
Volume 78, Issue 6, Pages (September 2010)
Pasquale Esposito, Teresa Rampino, Giuseppe Sileno, Antonio Dal Canton 
Volume 67, Issue 4, Pages (April 2005)
V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli 
Measuring transport of water across the peritoneal membrane
Severe exfoliative skin rash with icodextrin
Volume 55, Issue 2, Pages (February 1999)
Volume 73, Pages S5-S17 (April 2008)
Pharmacokinetics of icodextrin in peritoneal dialysis patients
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Volume 58, Issue 2, Pages (August 2000)
Blood pressure targets in hemodialysis patients
Volume 61, Issue 4, Pages (April 2002)
Volume 54, Issue 2, Pages (August 1998)
Peritoneal dialysis adequacy and risk of death
Volume 76, Issue 6, Pages (September 2009)
Volume 54, Issue 3, Pages (September 1998)
Dmytro Khadzhynov, MD, Christian Joukhadar, MD, Harm Peters, MD 
Water-only pores and peritoneal dialysis
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Nephrology Crossword: Peritoneal Dialysis
Future of icodextrin as an osmotic agent in peritoneal dialysis
A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis  Nigel S. Kanagasundaram, A. Brett Larive, Emil.
Volume 55, Issue 4, Pages (April 1999)
Profiling of peritoneal ultrafiltration
Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD- equivalent Kt/Vurea  Scott J. Schurman, Lawrence R. Shoemaker, Bradley.
Volume 73, Pages S72-S75 (April 2008)
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
Volume 60, Issue 2, Pages (August 2001)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
The course of the remnant kidney model in mice
Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms  Bert Bammens, Pieter Evenepoel, Kristin.
Volume 80, Issue 10, Pages (November 2011)
Volume 59, Issue 4, Pages (April 2001)
Treatment of the primary hyperoxalurias: A new chapter
Quantification of free water transport in peritoneal dialysis
Review of clinical trial experience with icodextrin
Volume 73, Issue 6, Pages (March 2008)
Volume 70, Issue 5, Pages (September 2006)
The removal of uremic toxins
Volume 65, Issue 1, Pages (January 2004)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 59, Issue 1, Pages (January 2001)
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Volume 58, Issue 4, Pages (October 2000)
Volume 57, Issue 4, Pages (April 2000)
Laura M. Krinsky, William J. Levine  Kidney International 
Metabolic and laboratory effects of icodextrin
Presentation transcript:

Volume 53, Issue 4, Pages 1014-1021 (April 1998) Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells  Caroline E. Douma, M.D., Ph.D., Johan K. Hiralall, Dirk R. de Waart, Dirk G. Struijk, Raymond T. Krediet  Kidney International  Volume 53, Issue 4, Pages 1014-1021 (April 1998) DOI: 10.1111/j.1523-1755.1998.00821.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 The time course of the transcapillary ultrafiltration (▪), lymphatic absorption (▾) and the resulting change in intraperitoneal volume (▴) with 7.5% icodextrin dialysate (A) and after the addition of nitroprusside (B). *P≤ 0.05 and **P≤ 0.01 when compared to the icodextrin experiment without nitroprusside. Kidney International 1998 53, 1014-1021DOI: (10.1111/j.1523-1755.1998.00821.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 The restriction coefficient for macromolecules without (-) and with (▾) nitroprusside in relation to the time treated with CAPD. Each individual patient is represented by an arrow. The length of the arrow indicates the magnitude of the effect of nitroprusside on the restriction coefficient. The regression lines are based upon the relationship between the time treated with CAPD and the restriction coefficient with icodextrin (r = 0.7, P = 0.04) and the CAPD treatment time and the restriction coefficient with icodextrin and nitroprusside (r=-0.1, P = 0.70). Kidney International 1998 53, 1014-1021DOI: (10.1111/j.1523-1755.1998.00821.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 The relationship between the MTAC of creatinine and the increase in intraperitoneal volume by icodextrin after eight hours. The ▴ shows the same relationship after the addition of nitroprusside. Arrows are drawn from the value without nitroprusside to the value after the addition of nitroprusside for each individual patient. Kidney International 1998 53, 1014-1021DOI: (10.1111/j.1523-1755.1998.00821.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Regression lines based upon the relationship between the median D/P ratios of urea, creatinine, urate and β2-microglobulin and their molecular weights (•). The positions of nitrate and cGMP (○) are given in relation to their molecular weight during various conditions. (A) Icodextrin at 240 minutes. (B) Icodextrin with nitroprusside at 240 minutes. (C) Icodextrin at 480 minutes. (D) Icodextrin with nitroprusside at 480 minutes. *P < 0.001 for increase in the observed D/P ratio cGMP with regard to the expected D/P ratio cGMP. Kidney International 1998 53, 1014-1021DOI: (10.1111/j.1523-1755.1998.00821.x) Copyright © 1998 International Society of Nephrology Terms and Conditions